Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1997

Primary Completion Date

August 31, 2000

Conditions
Prostate Cancer
Interventions
DRUG

estramustine phosphate sodium

DRUG

paclitaxel

Trial Locations (2)

10016

Kaplan Cancer Center, New York

10029

Mount Sinai Medical Center, NY, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER